Affimed
Affimed Logo
About Affimed
Affimed N.V. is a clinical-stage biopharmaceutical company specializing in the discovery and development of targeted cancer immunotherapies. The company focuses on activating the innate immune system, particularly natural killer (NK) cells, to eradicate solid and hematologic tumors. Its lead product candidates include AFM13 for lymphoma, AFM24 for advanced cancers, and AFM28 and AFM32, both innate cell engagers in preclinical development for hematologic malignancies and solid tumors. Affimed collaborates with partners such as Artiva Biotherapeutics, Roivant Sciences, and Genentech to advance novel immuno-oncology therapies. Headquartered in Mannheim, Germany, Affimed develops therapies to address unmet needs in cancer treatment worldwide.
Address
Gottlieb-Daimler-Straße 2,
Mannheim, 68165
Germany
Year founded
1970
Number of employees
0-100
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
